Skip to main content
Ran Reshef, MD, Oncology, New York, NY

RanReshefMDMSc

Oncology • New York, NY

Hematologic Oncology

Associate Professor, Medicine, Columbia University Medical Center

Request Appointment

Overview of Dr. Reshef

Dr. Ran Reshef is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Tel Aviv University Sackler and has been in practice 19 years. Dr. Reshef accepts several types of health insurance, listed below. He is one of 378 doctors at New York-Presbyterian Hospital and one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He also speaks multiple languages, including Hebrew. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2009
  • Tel Aviv University Sackler
    Tel Aviv University SacklerClass of 1998

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2015 - 2026
  • PA State Medical License
    PA State Medical License 2007 - 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value in Isolation or with Other Graft-Versus-Host Disease Symptoms as Currently Diagnos...  
    Margaret MacMillan, Sophie Paczesny, Ran Reshef, Daniel Weisdorf, Haematologica

Abstracts/Posters

  • The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
    Ran Reshef, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients...
    Ran Reshef, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Autologous Transplant Recipients Have a Healthier Gut Microbiota at Baseline and Faster Recovery from Microbiome Injury Compared to Allogeneic Transplant Recipients
    Ran Reshef, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • ZUMA-11: A Phase 1/2 Multicenter Study of Axicabtagene Ciloleucel (Axi-Cel) + Utomilumab Patients with Refractory Large B Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Certain Donors with High T Cell Counts Make a Better Match for Stem-Cell Transplant Patients, Study Suggests
    Certain Donors with High T Cell Counts Make a Better Match for Stem-Cell Transplant Patients, Study SuggestsJune 8th, 2015

Professional Memberships

Other Languages

  • Hebrew

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AmeriHealth Direct POS
    Amerihealth HMO
    AmeriHealth PPO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    Health Net HMO - Employer Group
    HealthAmerica HealthAssurance PPO
    Horizon BCBS Direct Access
    Horizon BCBS HMO
    Horizon BCBS POS
    Horizon BCBS PPO
    Humana ChoiceCare Network PPO
    IBC Keystone HMO / POS
    IBC Personal Choice PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Ran Reshef, Dr. Ran Reshef, MD, Dr. R Reshef